Medpace Holdings, Inc.
MEDP
$428.03
$11.992.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.97% | 13.88% | 9.94% | 9.87% | 11.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.97% | 13.88% | 9.94% | 9.87% | 11.84% |
| Cost of Revenue | 7.34% | 5.69% | 4.62% | 4.52% | 6.87% |
| Gross Profit | 26.01% | 17.88% | 12.57% | 12.58% | 14.38% |
| SG&A Expenses | 9.64% | 11.74% | 17.56% | 15.89% | 11.67% |
| Depreciation & Amortization | -3.85% | -0.76% | 3.17% | 6.68% | 11.10% |
| Other Operating Expenses | 34.62% | 16.73% | 5.65% | 4.50% | 6.58% |
| Total Operating Expenses | 20.04% | 11.39% | 6.41% | 5.73% | 7.31% |
| Operating Income | 19.71% | 24.03% | 25.18% | 28.65% | 32.67% |
| Income Before Tax | 13.96% | 20.03% | 24.72% | 32.80% | 41.78% |
| Income Tax Expenses | 27.56% | 28.83% | 34.31% | 30.03% | 35.30% |
| Earnings from Continuing Operations | 11.56% | 18.42% | 23.11% | 33.24% | 42.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.56% | 18.42% | 23.11% | 33.24% | 42.99% |
| EBIT | 19.71% | 24.03% | 25.18% | 28.65% | 32.67% |
| EBITDA | 18.26% | 22.40% | 23.67% | 27.08% | 31.11% |
| EPS Basic | 19.85% | 23.90% | 25.28% | 32.78% | 42.01% |
| Normalized Basic EPS | 22.70% | 26.04% | 27.18% | 32.18% | 40.73% |
| EPS Diluted | 21.05% | 25.23% | 26.54% | 33.55% | 42.24% |
| Normalized Diluted EPS | 23.96% | 27.36% | 28.35% | 32.83% | 41.02% |
| Average Basic Shares Outstanding | -6.79% | -4.47% | -1.79% | 0.52% | 0.76% |
| Average Diluted Shares Outstanding | -7.75% | -5.45% | -2.64% | 0.06% | 0.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |